We are live on ! Find out more
ENZ icon

Enzo Biochem

Delisted

ENZ was delisted on the 17th of April, 2025.

116 hedge funds and large institutions have $313M invested in Enzo Biochem in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 32 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital inflows, than outflows

Capital inflows: $26.4M | Capital outflows: $18.4M

28% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 32

1.31% more ownership

Funds ownership: 62.89% → 64.2% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 120 → 116 (-4)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

62% less call options, than puts

Call options by funds: $436K | Put options by funds: $1.16M

Holders
116
Holders Change
-4
Holders Change %
-3.33%
% of All Funds
2.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
41
Reduced
32
Closed
22
Calls
$436​K
Puts
$1.16​M
Net Calls
-⁠$719​K
Net Calls Change
-⁠$1.43​M

ENZ Hedge Fund Activity: Q3 2017 in Review

116 of the 4,024 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem (ENZ) for Q3 2017, worth a combined $313M — down 2.9% from $322M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ENZ and 18 opened new positions — a net loss of 4 holders — while 32 trimmed existing stakes and 41 added.

The largest buyer was TIAA CREF Investment Management, adding an estimated $2.24M. The largest seller was First Light Asset Management, cutting an estimated $1.97M.

  • 116 institutional investors held Enzo Biochem (ENZ) as of Q3 2017, down from 120 in Q2 2017.
  • Funds reported $313M of Enzo Biochem stock for Q3 2017, down 2.9% quarter-over-quarter.
  • 18 funds opened new Enzo Biochem positions in Q3 2017 and 22 closed out, a net change of -4 holders.
  • The largest Enzo Biochem buyer in Q3 2017 was TIAA CREF Investment Management, an estimated $2.24M added.
  • The largest Enzo Biochem seller in Q3 2017 was First Light Asset Management, an estimated $1.97M sold.

Based on aggregated 13F filings for Q3 2017.